Plain-English translation of NCT06153069 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether people with asymptomatic tuberculosis — meaning you have the infection but no symptoms — can be treated successfully with shorter courses of medication. Researchers are comparing three different treatment lengths: a standard 6-month regimen, a 4-month regimen, and a 3-month regimen using rifapentine, isoniazid, pyrazinamide, and moxifloxacin. The goal is to find out if shorter treatments work just as well while being easier for patients to complete.
Standard TB treatment takes 6 months, which is a long time to take daily medications and increases the risk that people will stop treatment early. This trial exists to see if newer, shorter medication combinations can cure asymptomatic TB just as effectively, which could help more people finish their treatment successfully.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of three treatment groups and take daily oral TB medications for either 3, 4, or 6 months. You'll have regular clinic visits where doctors will check on your health, monitor how well the medication is working through tests and imaging, and watch for any side effects. The trial involves blood tests, chest X-rays, and sputum samples to track your progress throughout treatment and after.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China